Single and Multiple Ascending Doses of AZD1981 in Japan

Phase 1

Completed

• Conditions: Healthy
• Interventions: Drug: AZD1981; Drug: Placebo

• Registration Number: NCT00698282
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-06-16
• Study First Submitted QC: 2008-06-16
• Study First Posted: 2008-06-17
• Study Start: 2008-08
• Primary Completion: 2008-10
• Study Completion: 2008-10
• Status Verified: 2010-11
• Last Update Submitted: 2010-11-30
• Last Update Posted: 2010-12-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 47

Inclusion Criteria

• Healthy Japanese and Caucasian males

Read More

Exclusion Criteria

• Other clinically relevant disease or disorders

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
1	AZD1981	-
2	AZD1981	-
3	Placebo	-

Primary Outcome Measures

Name	Time	Method
Adverse events	All the time
Plasma drug concentration	Every hour

Secondary Outcome Measures

Name	Time	Method
Clinical chemistry	day 1 and 9

Trial Locations

Locations (1)

Research Site; 🇬🇧 Berkshire, United Kingdom